Establishment Labs (NASDAQ:ESTA) versus Ascendant Solutions (OTCMKTS:MYDP) Head to Head Comparison

Establishment Labs (NASDAQ:ESTAGet Free Report) and Ascendant Solutions (OTCMKTS:MYDPGet Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

Earnings and Valuation

This table compares Establishment Labs and Ascendant Solutions”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Establishment Labs $229.58 million 9.25 -$51.06 million ($1.49) -48.45
Ascendant Solutions N/A N/A N/A N/A N/A

Ascendant Solutions has lower revenue, but higher earnings than Establishment Labs.

Analyst Ratings

This is a summary of recent ratings for Establishment Labs and Ascendant Solutions, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs 1 1 6 0 2.63
Ascendant Solutions 0 0 0 0 0.00

Establishment Labs presently has a consensus price target of $87.14, indicating a potential upside of 20.71%. Given Establishment Labs’ stronger consensus rating and higher possible upside, analysts clearly believe Establishment Labs is more favorable than Ascendant Solutions.

Insider and Institutional Ownership

72.9% of Establishment Labs shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 31.6% of Ascendant Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Establishment Labs and Ascendant Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Establishment Labs -19.05% -218.77% -12.31%
Ascendant Solutions N/A N/A N/A

Summary

Establishment Labs beats Ascendant Solutions on 5 of the 9 factors compared between the two stocks.

About Establishment Labs

(Get Free Report)

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

About Ascendant Solutions

(Get Free Report)

Dougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.

Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.